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Abstract 
Background: To effectively treat orthopaedic infections by methicillin-resistant strains, an early diagnosis is neces-
sary. Bacterial cultures and real-time polymerase chain reaction (PCR) have been used to define methicillin-resistant 
staphylococci. However, even when patients display clinical signs of infections, bacterial culture and real-time PCR 
often cannot confirm infection. The aim of this study was to prospectively compare the utility of real-time PCR for the 
mecA gene detection following centrifugation of human samples with suspected orthopaedic infections.
Results: In addition to the conventional real-time PCR method, we performed real-time PCR following centrifugation 
of the sample at 4,830×g for 10 min in a modified real-time PCR (M-PCR) method. We suspended cultured methicillin-
resistant Staphylococcus aureus and generated standard dilution series for in vitro experiments. The in vitro detection 
sensitivity of the M-PCR method was approximately 5.06 times higher than that of the conventional real-time PCR 
method. We performed bacterial culture, pathological examination, real-time PCR, and M-PCR to examine the infec-
tious fluids and tissues obtained from 36 surgical patients at our hospital. Of these, 20 patients who had undergone 
primary total hip arthroplasty were enrolled as negative controls. In addition, 15 patients were examined who were 
clinically confirmed to have an infection, including periprosthetic joint infection (eight patients), pyogenic spondylitis 
(two patients), infectious pseudoarthrosis (two patients), and after spine surgery (three patients). In one sample from 
a patient who developed infectious pseudoarthrosis and two samples from surgical site infections after spine surgery, 
the mecA gene was detected only by the M-PCR method. In one patient with infectious pseudoarthrosis, one patient 
with infection after arthroplasty, and two patients with purulent spondylitis, the detection sensitivity of the M-PCR 
method was increased compared with PCR (clinical sample average: 411.6 times).
Conclusions: These findings suggest that the M-PCR method is useful to detect methicillin-resistant strains infec-
tions. In addition, the centrifugation process only takes 10 min longer than conventional real-time PCR methods. 
We believe that the M-PCR method could be clinically useful to detect orthopaedic infections caused by methicillin-
resistant strains.
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Background
Orthopaedic procedures in particular are associated 
with a risk of surgical-site infection (SSI) [1]. The inci-
dence of SSI following orthopaedic surgery in Japan is 
0.83% for cases of spinal canal stenosis, 0.28% for cases 
of disc herniation, 0.80% for cases of total hip arthro-
plasty (THA), and 0.96% for cases of total knee arthro-
plasty (TKA) [2, 3]. Orthopaedic procedures are also 
being performed in a growing number of patients with 
co-morbid conditions such as diabetes mellitus and 
in increasingly elderly patients, both of which are fac-
tors known to increase the risk of SSI [4]. Prosthetic 
joint infections by multidrug-resistant bacteria com-
prise one of the most important and complex prob-
lems in orthopaedic surgery. The most important and 
frequently resistant bacteria involved in infection of 
total joint replacements include methicillin-resistant 
Staphylococcus aureus (MRSA), methicillin-resistant 
coagulase-negative Staphylococci, vancomycin-resistant 
enterococci, multidrug-resistant Pseudomonas aerugi-
nosa, and Acinetobacter baumannii [5]. Although cul-
ture of samples remains the standard for identifying 
most organisms causing infection, diagnoses based on 
culture suffer from a high rate of false negatives caused 
by insufficient numbers of viable bacteria and effects of 
previous antibiotic therapy [6]. To resolve these prob-
lems, several techniques, including polymerase chain 
reaction (PCR) detection, have been developed to 
obtain results faster and more accurately than by using 
culture methods [7–20]. PCR amplification can detect 
the mecA gene, which gives rise to methicillin-resist-
ance, in orthopaedic prosthetic infections [8, 21–26]. 
Although real-time PCR methods have been exploited 
for rapid, sensitive, and reproducible detection [27], 
sensitivity and specificity of the diagnosis using PCR 
were 87 and 80% in clinical use, respectively [28]. PCR 
can theoretically detect mecA gene from a single copy 
of DNA. However, the probability that this single copy 
would be amplified is low, so many copies are needed to 
reach a “detection threshold” [13]. We tried to improve 
the rate of positive identification of the mecA gene in 
these challenging situations. The aim of this cohort 
study was to compare the utility of real-time PCR for 
mecA gene identification in vitro and in clinical samples 
following centrifugation of samples. We found that cen-
trifugation of these samples improves detection of the 
mecA gene.
Figure 1 M-PCR improved detection of the mecA gene in vitro. To 
compare the detection sensitivity of the M-PCR method with the 
conventional real-time PCR method, we created a dilution series 
using cultured MRSA (×1:1 time; ×10:10 times; ×100:100 times). DNA 
was purified by conventional methods (A) or following centrifuga-
tion (B: M-PCR). Centrifugation promoted more rapid arrival at the 
threshold cycle (Fluorescence: 0.56). A comparative Ct (ΔCt) analysis 
was performed to examine fold changes of the mecA gene. The 
experiment was performed in triplicate with similar results.
Results
M‑PCR improved the mecA gene detection in vitro
We hypothesized that centrifugation would enrich the 
number of bacteria in the samples, improving detection of 
the mecA gene of MRS. First, we examined several condi-
tions in which to precipitate cultured MRSA by centrifu-
gation of MRSA-containing phosphate-buffered saline 
(PBS). We chose to centrifuge at 4,830×g for 10 min. Then 
we performed conventional PCR and M-PCR using the 
same MRSA dilution series. M-PCR improved detection 
of the mecA gene 5.06-fold over that achieved with con-
ventional real-time PCR methods (Figure  1). There was 
statistical difference between M-PCR and conventional 
real-time PCR (p < 0.05).
M‑PCR did not enrich the mecA gene of killed bacteria
It is possible that PCR detects the mecA gene from DNA 
of killed MRS because killed bacteria release genomic 
DNA into the extracellular environment by autolysis [29]. 
Theoretically, genomic DNA of MRSA is too small to be 
precipitated by centrifugation at 4,830×g for 10 min. In 
order to examine whether M-PCR increases the detec-
tion of released DNA, DNA was first purified from cul-
tured MRSA by DNA purification. We then performed 
centrifugation of DNA-containing PBS. M-PCR did not 
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increase the sensitivity for detecting the mecA gene (Fig-
ure  2). These findings suggest that the released DNA is 
too small to be precipitated by centrifugation at 4,830×g 
for 10 min.
M‑PCR improved detection of the mecA gene in clinical 
specimens
We analysed the effusion, joint fluid, or infectious tis-
sues from the infectious sites. The demographic data are 
summarized in Additional file 1: Table S1. Conventional 
PCR and M-PCR did not detect the mecA gene from 
control primary THA samples. Only M-PCR, and not 
conventional PCR, detected the mecA gene from three 
clinically infected samples, including one pseudoar-
throsis and two surgical site infections following spine 
surgery (Figure  3). In seven samples, detection of the 
mecA gene was improved by M-PCR. Overall, M-PCR 
improved detection of the mecA gene 411.6 (average) 
times than was achieved with conventional real-time 
PCR. There was statistical difference between M-PCR 
and conventional real-time PCR (p < 0.05). The results 
for all of the clinical samples are summarized in Addi-
tional file 2: Table S2.
Discussion
The identification of microorganisms is crucial for the 
treatment of orthopaedic infections. Conventional bac-
teriological culture of single samples obtained from 
infectious sites has a high rate of false-positive and false-
negative results [30]. Given the limitations of culture, 
PCR is often used as an additional diagnostic tool for 
orthopaedic infections [13, 16, 17, 29, 31]. The over-
all sensitivity in diagnosing prosthetic joint infections 
increased to 67% when both PCR and bacterial culture 
were examined together [16]. Mariani et al. reported that 
although PCR provides greater sensitivity than standard 
diagnostic tests, such as culture and pathological exami-
nations [25], the sensitivity of PCR was not high enough 
(50%). To address this, we tried to improve the detection 
sensitivity of real-time PCR methods. Our findings show 
that the sensitivity of the M-PCR method was higher 
than that of the conventional real-time PCR method 
both in  vitro and in clinical samples. No contaminants 
were detected in our series, and no mecA gene DNA was 
found in samples from patients who had undergone pri-
mary total hip arthroplasty (i.e., there were no false-pos-
itive results). Several agents are available to treat MRSA, 
including vancomycin, teicoplanin, and daptomycin. 
Although detection of the mecA gene by PCR could not 
distinguish between mecA-positive coagulase-negative 
Staphylococci and MRSA, these anti-MRS agents can be 
used to treat infection caused by both strains.
One stage or two-stage re-implantation is considered 
the standard procedure to treat prosthetic joint infec-
tions. Many factors affect the outcomes of patients with 
implant-related infections, including MRSA infections 
[32–35]. In addition, Trisha et  al. reported that MRSA 
were isolated in 45% of all prosthetic joint infections [36]. 
To address this issue, we attempted to improve the detec-
tion sensitivity of the mecA gene. Our findings show that 
the M-PCR method improves the detection sensitivity 
of the mecA gene in orthopaedic infections, and it only 
takes an additional 10  min compared with the conven-
tional real-time PCR method. In addition, it costs very 
little because most laboratories already own a centrifuge. 
Enrichment of bacterial DNA by centrifugation for real-
time PCR could be useful to evaluate orthopaedic infec-
tions, especially after initiating antibiotic therapy, which 
decreases the number of bacteria.
We showed that M-PCR detected the mecA gene from 
three clinically infected samples that were not detected 
by conventional PCR. Culture of these samples could not 
detect the pathogenic bacteria either. We could admin-
ister anti-MRSA antibiotics to these three patients and 
treat the infection based on the M-PCR results. These 
findings show that M-PCR is clinically useful.
Although real-time PCR may detect DNA released 
from dead bacteria, our findings suggest that centri-
fuging purified bacterial DNA did not improve the rate 
of detecting the mecA gene using the M-PCR method. 
These findings indicate that the released DNA fragments 
were too short to be precipitated by centrifugation at 
4,830×g for 10 min.
Figure 2 M-PCR did not increase detection of the mecA gene in puri-
fied DNA. To compare the detection sensitivity of the M-PCR method 
with the conventional real-time PCR method, we made diluent using 
the purified DNA of MRSA. DNA was first purified from cultured MRSA 
and dissolved in 5 mL PBS. Next, DNA was purified by conventional 
methods (A) or following centrifugation (B: M-PCR). A comparative Ct 
(ΔCt) analysis was performed to examine fold changes of the mecA 
gene. The results showed that M-PCR did not increase the detection 
of the mecA gene in purified DNA. The experiment was performed in 
triplicate with similar results.
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Several limitations remain to be addressed by the 
M-PCR approach. Because the number of patients is still 
low, we do not have enough findings to demonstrate the 
effectiveness of our M-PCR methods. In addition, centrif-
ugation might increase the collection of bacterial DNA 
that is still contained within dying or recently dead bac-
teria. Also, concentrating the specimen may increase the 
amount of PCR inhibitors and impurities in the extracted 
DNA and reduce the sensitivity of the PCR. It has been 
reported that a wide range of bacteria are potentially 
associated with orthopaedic infections [12, 36]. Further 
research is required to determine whether M-PCR could 
be useful to identify other bacteria as well.
Conclusions
Real-time PCR following centrifugation of samples can 
improve the detection of the mecA gene in orthopaedic 
infections. It improved the diagnosis of MRS infections 
and could be used for patients with suspected ortho-
paedic infections when culture or conventional PCR are 
negative, and in the diagnosis of patients receiving anti-
microbial treatment. Improvements in the mecA gene 
detection by the M-PCR method may help to treat MRS 
infections in orthopaedic operations, improving patient 
outcomes and decreasing costs for the hospital.
Methods
Bacterium
A cultured methicillin-resistant staphylococcal strain 
that was obtained from patients with MRSA sinus infec-
tions was used for the in vitro portion of this study and 
was a positive control for mecA gene PCR. MRSA was 
identified by Staphyogram (Terumo, Tokyo, Japan), 
an identification kit, and the coagulase test. Bacterial 
colonies were suspended in 5  mL of trypcase soy broth 
(TSB-ST), 4% NaCl, and 25% glucose. Bacterial culture 
was performed on a shaker overnight at 37°C.
Patients
In total, 35 patients hospitalized at the Department of 
Orthopaedic Surgery of Kagoshima University Hos-
pital in Japan were included in this study. Of these, 20 
patients who had undergone primary total hip arthro-
plasty were used as negative controls. In these controls, 
infection was excluded by negative results from cultures 
of three surgical samples and normal C-reactive pro-
tein levels, white blood cell counts, and the neutrophil 
count. In addition, 15 patients were examined who were 
confirmed to have clinically defined infection, including 
periprosthetic joint infection (eight patients), pyogenic 
spondylitis (two patients), infectious pseudoarthrosis 
(two patients), and after spine surgery (three patients). 
The diagnosis of orthopaedic infections was made based 
on clinical presentation, laboratory data, and diagnostic 
imaging. The clinical symptoms were pain, local swelling 
and heat, tenderness, aspiration of purulent joint fluid, 
and purulence surrounding the disease site at the time 
of surgery [37, 38]. Laboratory findings suggestive of bio-
logical inflammatory syndrome were an elevated white 
blood cell count, erythrocyte sedimentation rate (ESR) 
(>30  mm/h), and C-reactive protein (CRP) (>1  mg/dL). 
In addition, synovial fluid or three tissues obtained surgi-
cally from the infectious site were cultured and examined 
histopathologically. These samples were placed in sterile 
tubes in the operating room and sent to our laboratory 
for bacterial culture and pathologic examination within 
24 h. Culture was performed in the routine work of the 
hospital clinical microbiology laboratory. The clinical and 
Figure 3 M-PCR improved the detection of mecA gene in clinical samples. To compare the detection sensitivity of the M-PCR method with the 
conventional real-time PCR method, we analysed infectious tissues collected from patients. DNA was purified by conventional methods (A) or fol-
lowing centrifugation (B: M-PCR). A comparative Ct (ΔCt) analysis was performed to examine fold changes of the mecA gene. Only M-PCR, but not 
conventional real-time PCR, detected the mecA gene from three clinically infected samples, including one pseudoarthrosis (a). M-PCR improved 
the detection of the mecA gene 6.96 times higher than conventional real-time PCR methods (b). The experiment was performed in triplicate with 
similar results.
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histopathological aspects of our study were also reviewed 
by a member of the infectious diseases control team and 
a pathologist.
Ethics statement
This research protocol was approved by the Ethics 
Committee on Clinical Research at Kagoshima Univer-
sity Hospital (Name of research: Enrichment of bacte-
ria samples by centrifugation improves the diagnosis of 
orthopaedics-related infections via real-time PCR ampli-
fication of the bacterial methicillin-resistance gene; No. 
25-115).
DNA extraction from cultured MRSA dilution series
We prepared two dilution series using culture solutions 
of MRSA. A total of 10 mg of a MRSA colony-containing 
agar was dissolved in 5 μL of culture medium and then 
cultured overnight. Then 500 μL of culture medium was 
added to 4,500  μL of PBS. The tenfold dilution series 
was prepared using PBS. For conventional PCR, DNA 
was purified from this dilution series using a QIAamp 
DNA Mini kit (QIAGEN) as per the manufacturer’s 
recommendations. Dilution series samples were centri-
fuged at 4,830×g for 10 min before DNA extraction for 
the M-PCR technique. The supernatants were discarded 
and the pellets dissolved in 200 µL of PBS. The DNA was 
purified using a QIAamp DNA Mini kit as per the manu-
facturer’s recommendations.
DNA extraction from killed MRSA
For the killed bacterium DNA detection assay, DNA was 
first purified from cultured MRSA using a DNA purifi-
cation kit (QIAamp DNA Mini kit) as per the manufac-
turer’s recommendations. We then dissolved a purified 
DNA by PBS. Samples were centrifuged at 4,830×g for 
10 min before DNA extraction for the M-PCR technique. 
The supernatants were discarded, and the pellets were 
dissolved in 200  µL PBS, as before. Finally, DNA was 
purified using a QIAamp DNA Mini kit.
DNA extraction from clinical specimens
Clinical samples (0.4 g) were divided into smaller pieces 
by scissors. These cleaved samples were dissolved in 
10 mL of PBS. Sonication was then performed at 20 kHz 
for 10 min (Tomy Seiko Co. Ltd., Tokyo, Japan). For con-
ventional PCR, 200 μL of the sample containing PBS was 
used. For M-PCR, 9,800  μL of the sample containing 
PBS was centrifuged at 4,830×g for 10 min before DNA 
extraction. The supernatants were discarded and the pel-
lets dissolved in 200 µL PBS. DNA was extracted follow-
ing the manufacture’s recommendations (QIAamp DNA 
Mini kit). DNA extracts were reconstituted in a final vol-
ume of 50 µL and stored at −20°C.
Real‑time PCR
The extracted DNA samples were examined by real-time 
PCR using the LightCycler® system (Roche Diagnostics, 
Mannheim, Germany). The LightCycler MRSA Detec-
tion Kit provides primers and probes for amplification 
and sequence-specific detection of the mecA gene. Five 
microlitres of the extracted DNA elution was added to 
the master mix at a final volume of 20 µL for each reac-
tion. The real-time PCR reaction was performed follow-
ing the kit manufacture’s recommendations. Briefly, the 
cycling conditions were a hot start at 95°C for 10  min, 
followed by 45 cycles of denaturation at 95°C for 10  s, 
annealing at 55°C for 10 s, and extension at 72°C for 12 s.
We also synthesized our own primers for the mecA 
gene and performed real-time PCR because the Light-
Cycler® MRSA Detection Kit has been discontinued. 
We used the Eco™ Real-time PCR System (Illumina, 
San Diego, CA, USA), and the primer was designed for 
the mecA gene as previously reported [39]. The forward 
and reverse primer sequences were: 5′-TGCTATCCAC-
CCTCAAACAGG-3′ and 5′-AACGTTGTAACCAC-
CCCAAGA-3′. The PCR mixtures totalled 20  μL per 
reaction, and consisted of 10 μM concentration of each 
primer and 10 μL of 2× Fast SYBR® Green Master Mix 
(Life Technologies Corporation, Carlsbad, SD). We added 
2  μL of the extracted DNA to the PCR mixture. Reac-
tion mixtures were incubated at 95°C for 20 s followed by 
40 cycles of 95°C for 3 s and 60°C for 20 s. We used the 
cultured MRSA as the positive control and nuclease-free 
water as the negative control.
Statistical analysis
A Statistical differences between groups were assessed by 
Mann–Whitney’s U test (Microsoft, Albuquerque, NM, 
USA). All statistical analyses were performed using and 
Excel Statics 2012 (SSRI, Osaka, Japan).
Patient consent
Written informed consent was obtained from patients 
and their families to publish this report. Copies of the 
written consent forms are available for review by the Edi-
tor-in-Chief of the journal.
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